During the past decade, McGill University Health Centre-Cedars Cancer Centre conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 21 clinical trials were completed, i.e. on average, 80.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McGill University Health Centre-Cedars Cancer Centre" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Pfizer" with 6 trials sponsored, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGill University Health Centre-Cedars Cancer Centre" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "McGill University Health Centre-Cedars Cancer Centre" are "Breast Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Prostate Cancer" (3 trials), "Ovarian Cancer" (2 trials) and "Triple-Negative Breast Cancer" (2 trials). Many other conditions were trialed in "McGill University Health Centre-Cedars Cancer Centre" in a lesser frequency.

Most popular intervention types in "McGill University Health Centre-Cedars Cancer Centre" are "Drug" (35 trials), "Radiation" (5 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Atezolizumab" (4 trials), "Cyclophosphamide" (4 trials), "Dexamethasone" (4 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.

The vast majority of trials in "McGill University Health Centre-Cedars Cancer Centre" are 31 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "McGill University Health Centre-Cedars Cancer Centre". undefined are not yet recruiting, 9 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in McGill University Health Centre-Cedars Cancer Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in McGill University Health Centre-Cedars Cancer Centre, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".